CompletedInterventionalPhase 1Phase 2Last updated Aug 18, 2017

Effect of Neostigmine on the Recovery of Rocuronium: A Comparison Between Partial and TOF Ratio-Based Dose

The Effectiveness of Neostigmine on the Recovery of Rocuronium-Induced Neuromuscular Blockade: A Comparison Between Partial Dose and TOF Ratio-Based Adjustment Dose

Overview

ClinicalTrials.gov ID: NCT03058263
Lead Sponsor: Indonesia UniversityOTHER
Brief Summary: This study aimed to evaluate the effect of Neostigmine partial dose towards neuromuscular blockade of rocuronium
Study Type: Interventional

Status

Overall Status: Completed
Start Date: Oct 2016Actual
Primary Completion Date: Feb 1, 2017Actual
Completion Date: Feb 28, 2017Actual

Study Record Dates

First Submitted: Feb 12, 2017
First Submitted that Met QC Criteria: Feb 15, 2017
First Posted: Feb 20, 2017Actual
Last Update Submitted that Met QC Criteria: Aug 15, 2017
Last Update Posted: Aug 18, 2017Actual
Last Verified: Aug 2017

NCT01885715Completed

Appropriate Dose of Neostigmine for Reversal of Rocuronium and Cisatracurium

NCT06794450Recruiting

Recovery Times of Half Dose Sugammadex and Neostigmine for Rocuronium-induced Neuromuscular Blockade

NCT00001520Completed

The Early Reversibility of Rocuronium After Different Doses of Neostigmine

NCT00451100Completed

Comparison of Rocuronium and Org 25969 With Cisatracurium and Neostigmine (19.4.310)(P05931)

NCT00847938Completed

Comparision of Different Dose of Neostigmine at Advanced Decurarization

NCT03322657Completed

Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular